Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Flu shots offered to populations at risk at the beginning of season

All Care Inala Medical Centre doctor Michael Ho said flu shots were becoming more popular each year. “Flu seasons tends to begin in late March early April to June,” he said. “More and more people are opting to get vaccinations because they are promoted well within the community.” He added, “It is particularly important for elderly people to be immunized because their immune system is already not at its best…This is also the case for people who have chronic medical conditions like diabetes, severe asthma, or heart disease. With their current condition, if they catch the flu they can end up with a worse outcome.”

12 Apr 2012

KineMed receives NIH RAID grant to advance FX-5A for heart disease

KineMed Inc. today announced its successful award of a Rapid Access to Intervention Development (RAID) peer-reviewed grant by the National Institute of Health to advance an HDL mimetic, designated FX-5A, designed to reverse atherosclerosis and heart disease.

12 Apr 2012

Screen time linked with obesity in children

Approximately 20 percent of adolescents in the U.S. today are obese or overweight. With the number of obese and overweight younger children close behind, this epidemic has lasting implications for the future.

12 Apr 2012

Johns Hopkins cardiologists support use of statins for primary prevention of heart attack

Writing the first commentary for a new feature in the Journal of the American Medical Association (JAMA), called Viewpoint, Johns Hopkins cardiologists make the case for why a 55-year-old man with a 10 percent estimated risk of heart attack over the next 10 years should be offered statin medication. They were invited to debate a professor who argues against prescribing statins for "primary" prevention—for those who have not had a cardiovascular event, such as a heart attack—even though they may be considered at "intermediate" risk because of elevated cholesterol or other factors.

12 Apr 2012

ECG abnormalities associated with increased risk of CHD in older adults

In a study that included elderly men and women without preexisting cardiovascular disease, major and minor electrocardiographic abnormalities were associated with an increased risk of coronary heart disease (CHD) events and improved the prediction of CHD events such as heart attack, beyond traditional cardiovascular risk factors, according to a study in the April 11 issue of JAMA.

12 Apr 2012

ST2 more specific than BNP for heart failure diagnosis

Critical Diagnostics today announced publication in the latest issue of the Journal of Heart Failure results of a study involving 995 patients who presented to the emergency room (ER) with chest pain. The study concluded that in this undifferentiated, symptomatic patient population ST2 was more specific for acute heart failure than BNP and that ST2 is independently predictive of future death and/or heart failure and has incremental utility in combination with BNP.

12 Apr 2012

Takeda enters definitive agreement to acquire URL Pharma

Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.

12 Apr 2012

University of Limerick researchers develop device to increase angioplasty success rates

Developed by biomedical engineers at the University of Limerick the device will improve success rates in angioplasty procedures. It is estimated that over 1 million angioplasty procedures are undertaken worldwide each year and the value of products relating to this procedure is in the region of €500million.

11 Apr 2012

Eye test to detect heart disease early

Scientists at the University of Edinburgh have developed the test which scans blood vessels in the retina at the back of the eyes. They are now launching a study involving more than 1,000 patients to see if the test is reliable.

11 Apr 2012

Fish oil not as beneficial for the heart as thought: Study

Fish oil, a combination of omega-3 fatty acids that has attracted much research on its effects on heart health. So far, the evidence has been inconclusive -- some studies have found fish oil has been major in preventing heart attacks, strokes and sudden cardiac death, while others have found fish oil has no benefits at all.

10 Apr 2012

DaVita introduces Kidney Smart website for patients with CKD

DaVita Inc., a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the launch of its Kidney Smart website, for anyone with questions about CKD.

10 Apr 2012

Lee's Pharma licenses rights to commercialize PL2200 Aspirin in China

PLx Pharma Inc, a Houston based pharmaceutical company developing gastrointestinal (GI) safer drugs has licensed to Lee's Pharmaceutical Holdings Limited (Lee's Pharma) the rights to register and commercialize in China, Hong Kong and Macau the PL2200 Aspirin, a GI safer aspirin product currently in development in the US, for prevention of cardiovascular diseases. Cardiovascular is one of the focus areas of Lee's Pharma.

10 Apr 2012

TCT 2012 to be held in Miami from Oct. 22-26

Media registration is now open online for TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation.

10 Apr 2012

Proteonomix provides corporate and clinical trial updates

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today provided updates on its progress.

10 Apr 2012

ReCor Medical provides updated data from REDUCE Percutaneous Renal Denervation System study

ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.

10 Apr 2012

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

Niacin, or vitamin B3, is the one approved drug that elevates "good" cholesterol (high density lipoprotein, HDL) while depressing "bad" cholesterol (low density lipoprotein , LDL), and has thereby attracted much attention from patients and physicians. Niacin keeps fat from breaking down, and so obstructs the availability of LDL building blocks.

9 Apr 2012

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

7 Apr 2012

NIH to award $20M over 5 years to support global health training for scientists

"A network of global health research training institutions will increasingly focus on the rising levels of chronic diseases in developing countries, the National Institutes of Health Fogarty International Center announced on Wednesday," CQ HealthBeat reports (Bristol, 4/4).

6 Apr 2012

Researchers understand TG paradox in people of African descent

In most people, high blood levels of the fat known as triglycerides are an early warning sign of type 2 diabetes and metabolic syndrome, but in people of African descent these dangerous health conditions may go undiagnosed because triglyceride levels are not at the level used to diagnose metabolic syndrome (>150 mg/dL). This is known as the "TG (or lipid) paradox."

6 Apr 2012

WHO drafts treaty to fight illicit tobacco trade; WTO demands Obama administration drop ban on flavored cigarettes

"Nations have crafted a draft treaty to fight a booming trade in illicit tobacco products that's costing governments as much as $50 billion a year in lost tax revenue, officials said Wednesday," the Associated Press/Washington Post reports.

6 Apr 2012

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Flu shots offered to populations at risk at the beginning of season

KineMed receives NIH RAID grant to advance FX-5A for heart disease

Screen time linked with obesity in children

Johns Hopkins cardiologists support use of statins for primary prevention of heart attack

ECG abnormalities associated with increased risk of CHD in older adults

ST2 more specific than BNP for heart failure diagnosis

Takeda enters definitive agreement to acquire URL Pharma

University of Limerick researchers develop device to increase angioplasty success rates

Eye test to detect heart disease early

Fish oil not as beneficial for the heart as thought: Study

DaVita introduces Kidney Smart website for patients with CKD

Lee's Pharma licenses rights to commercialize PL2200 Aspirin in China

TCT 2012 to be held in Miami from Oct. 22-26

Proteonomix provides corporate and clinical trial updates

ReCor Medical provides updated data from REDUCE Percutaneous Renal Denervation System study

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

NIH to award $20M over 5 years to support global health training for scientists

Researchers understand TG paradox in people of African descent

WHO drafts treaty to fight illicit tobacco trade; WTO demands Obama administration drop ban on flavored cigarettes

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in